BCAS2P2

Across TCGA pan-cancer cohorts, BCAS2P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of BCAS2P2’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where BCAS2P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BCAS2P2 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

LUAD, BRCA, and KICH are the cancer types where BCAS2P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BCAS2P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.444	.001	7	view →
BRCA	Female	All	+0.312	.003	4	view →
KICH	All	All	−0.108	.004	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

BCAS2P2–LUAD

Open the LUAD breakdown →